🇺🇸 FDA

Company profile · Sponsor

MapLight

MapLight Therapeutics

MPLT · NYSE pharma REDWOOD CITY, CA, USA
Pipeline
5
Drugs
0
Patents
0

Quick answer

MapLight (MPLT) is a pharma company. headquartered in REDWOOD CITY, CA, USA. listed on NYSE. NovaPharmaNews links 5 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker MPLT
Exchange NYSE
Company type pharma
Headquarters REDWOOD CITY, CA, USA
SEC CIK 0001770069

Pipeline (5)

Search pipeline →

  1. ML-004 (IR)/(ER) tablet

    MapLight

    Autism Spectrum Disorder

    phase 2 small molecule active

    2 trials

  2. ML-007C-MA

    MapLight

    Psychosis Associated With Alzheimer's Disease

    phase 2 small molecule active

    2 trials

  3. ML-007C-MA

    MapLight

    Schizophrenia

    phase 2 small molecule active

    1 trial

  4. Placebo

    MapLight

    Schizophrenia

    phase 2 small molecule active

    1 trial

  5. Placebo for ML-007C-MA bilayer tablet

    MapLight

    Hallucinations and Delusions Associated with Alzheimer’s Disease Psychosis

    phase 2 small molecule active

    1 trial

Frequently asked questions

What is MapLight?

MapLight (MPLT) is a pharma company. headquartered in REDWOOD CITY, CA, USA. listed on NYSE. NovaPharmaNews links 5 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does MapLight sponsor?

We track 5 ClinicalTrials.gov-linked programs for MapLight, including ML-004 (IR)/(ER) tablet and 4 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does MapLight company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.